208ms

Oncology High-Yield Topics

Topics with the highest number of questions.

# Topic Importance Score Questions
1 Lung Cancer
A
0 13
2 Primary Brain Tumors
A
0 11
3 Malignant Bone Tumors
A
0 7
4 Multiple Myeloma
A
0 7
5 Squamous Cell Carcinoma (SCC) of the Skin
A
0 7
6 Melanoma
A
0 7
7 Acute Myelogenous Leukemia (AML)
A
0 6
8 Acute Lymphoblastic Leukemia (ALL)
A
0 6
9 Antimetabolites
A
0 6
10 Ovarian Tumors
A
0 5
11 Renal Cell Carcinoma
A
0 5
12 Malignant Breast Tumors
A
0 5
13 Colorectal Cancer (CRC)
A
0 5
14 Tumor Suppressor Genes
A
0 5
15 Thyroid Cancer
A
0 5
16 Benign Bone Tumors
A
0 4
17 Targeted Therapy
A
0 4
18 Pancoast Tumor
B
0 4
19 Polycythemia Vera
B
0 4
20 Hepatocellular Carcinoma (HCC)
A
0 4
21 Principles of Neoplasia
A
0 4
22 Gastric Cancer
B
0 4
23 Microtubule Inhibitors
A
0 4
24 Myelofibrosis
C
0 3
25 Metastasis
B
0 3
26 Testicular Tumors
A
0 3
27 Tumor Markers
C
0 3
28 Prostate Cancer
B
0 3
29 Esophageal Cancer
B
0 3
30 Non-Hodgkin Lymphoma
A
0 3
31 Bladder Cancer
B
0 3
32 Alkylating Agents
B
0 2
33 Hairy Cell Leukemia (HCL)
C
0 2
34 Endometrial Carcinoma
C
0 2
35 Choriocarcinoma
A
0 2
36 Cholangiocarcinoma
C
0 2
37 Langerhans Cell Histiocytoses
C
0 2
38 Cervical Cancer
B
0 2
39 Antitumor Antibiotics
B
0 2
40 Angiosarcoma
C
0 2
41 Chronic Myeloid Leukemia (CML)
B
0 2
42 Oncogenes
B
0 2
43 Hodgkin Lymphoma
C
0 2
44 Platinum Analogs
C
0 2
45 Basal Cell Carcinoma of the Skin
C
0 2
46 Tumor Nomenclature
C
0 2
47 Pancreatic Cancer
C
0 2
48 Soft Tissue Tumors
B
0 2
49 Vaginal Carcinoma
C
0 2
50 Chronic Lymphocytic Leukemia (CLL)
C
0 2
51 Parathyroid Adenoma
C
0 2
52 Oncogenic Viruses
B
0 2
53 Salivary Gland Tumors
D
0 1
54 Hepatic Adenoma
B
0 1
55 Waldenstrom Macroglobulinemia
C
0 1
56 Penis Cancer
C
0 1
57 Gallbladder Adenocarcinoma
C
0 1
58 Mycosis Fungoides / Sezary Syndrome
D
0 1
59 Anal Cancer
D
0 1
60 Essential Thrombocytosis
C
0 1
61 Cancer Drugs Overview
C
0 1
62 Mesothelioma 0 1
63 Wilms Tumor
C
0 1
64 Chemical Carcinogens
C
0 1

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options